Dual Inhibition of IL-2-Inducible T-Cell Kinase (ITK) and Tropomyosin Receptor Kinase A (TRKA) as Potential Treatment for Atopic Dermatitis and Other Inflammatory and Autoimmune Diseases
Abstract
ADVERTISEMENT RETURN TO ISSUEPREVPatent HighlightNEXTDual Inhibition of IL-2-Inducible T-Cell Kinase (ITK) and Tropomyosin Receptor Kinase A (TRKA) as Potential Treatment for Atopic Dermatitis and Other Inflammatory and Autoimmune DiseasesAhmed F. Abdel-Magid*Ahmed F. Abdel-MagidTherachem Research Medilab, LLC, 100 Jade Park, Chelsea, Alabama 35043, United States*Email: [email protected]More by Ahmed F....
Paper Details
Title
Dual Inhibition of IL-2-Inducible T-Cell Kinase (ITK) and Tropomyosin Receptor Kinase A (TRKA) as Potential Treatment for Atopic Dermatitis and Other Inflammatory and Autoimmune Diseases
Published Date
Nov 19, 2021
Volume
12
Issue
12
Pages
1889 - 1891
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History